Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Drug Notebook

FDA Alerts

    Cardiovascular Risk
  • Possible increased risk of serious (sometimes fatal) cardiovascular thrombotic events (e.g., MI, stroke). Risk may increase with duration of use. Individuals with cardiovascular disease or risk factors for cardiovascular disease may be at increased risk. (See Cardiovascular Effects under Cautions.)
  • Contraindicated for the treatment of pain in the setting of CABG surgery.

    GI Risk
  • Increased risk of serious (sometimes fatal) GI events (e.g., bleeding, ulceration, perforation of the stomach or intestine). Serious GI events can occur at any time and may not be preceded by warning signs and symptoms. Geriatric individuals are at greater risk for serious GI events. (See GI Effects under Cautions.)

Media Gallery
Drug Info Tools
Search by color, shape and markings. click here
Check any 2 drugs for interactions. click here
Compare any two drugs side by side. click here
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
diclofenac
(dye KLOE fen ak)
93 / 1041 | 100 mg93 / 1041   100 mg
bottle, 100 each Diclofenac Sod 100mg, Oral tablet, extended release, pink, round-shaped, side 1:93, side 2:1041
GG 904 | 100 mgGG 904   100 mg
bottle, 100 each Diclofenac Sod 100mg, Oral tablet, extended release, pink, round-shaped, side 1:GG 904
DX 41 | 100 mgDX 41   100 mg
bottle, 100 each Diclofenac Sod 100mg, Oral tablet, extended release, pink, convex, round-shaped, side 1:DX 41
Voltaren XR / 100 | 100 mgVoltaren XR / 100   100 mg
bottle, 100 each Diclofenac Sod 100mg, Oral tablet, extended release, pink, biconvex, round-shaped, side 1:Voltaren XR, side 2:100
Voltaren XR / 100 | 100 mgVoltaren XR / 100   100 mg
bottle, 100 each Diclofenac Sod 100mg, Oral tablet, extended release, pink, biconvex, round-shaped, side 1:Voltaren XR, side 2:100
Back to Top